|
| Status |
Public on May 04, 2023 |
| Title |
Neutralizing IFNγ improves safety without compromising efficacy of CAR-T cell therapy in B-cell malignancies |
| Platform organism |
Homo sapiens |
| Sample organisms |
Homo sapiens; Mus musculus |
| Experiment type |
Expression profiling by array
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| Web link |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256701/#MOESM6
|
| |
|
| Citation(s) |
37296093 |
| |
| Submission date |
Apr 04, 2023 |
| Last update date |
Aug 14, 2023 |
| Contact name |
Marika Guercio |
| E-mail(s) |
marika.guercio@opbg.net
|
| Phone |
0039 3339390943
|
| Organization name |
Ospedale Pediatrico Bambino Gesù
|
| Department |
Oncohematology
|
| Street address |
Viale di San Paolo, 15
|
| City |
Rome |
| State/province |
RM |
| ZIP/Postal code |
00146 |
| Country |
Italy |
| |
|
| Platforms (2) |
| GPL29417 |
NanoString nCounter CAR-T Characterization panel [NS_Hs_CART_v1.0] |
| GPL33312 |
nCounter Human Glial Profiling Panel |
|
| Samples (22)
|
|
| This SuperSeries is composed of the following SubSeries: |
| GSE228921 |
Neutralizing IFNγ improves safety without compromising efficacy of CAR-T cell therapy in B-cell malignancies I |
| GSE228922 |
Neutralizing IFNγ improves safety without compromising efficacy of CAR-T cell therapy in B-cell malignancies II |
|
| Relations |
| BioProject |
PRJNA952188 |
Less...
More...